347850 — DND Pharmatech Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩322bn
- KR₩323bn
- KR₩19bn
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Cash and Short Term Investments | 60,612 | 75,958 | 25,504 | 15,642 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 149 | 133 | 438 | 1,521 |
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 66,544 | 81,692 | 33,355 | 19,565 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 8,147 | 10,966 | 3,024 | 6,422 |
Net Goodwill | ||||
Net Intangible Assets | ||||
Long Term Investments | ||||
Long Term Notes Receivable | ||||
Other Long Term Assets | ||||
Total Assets | 229,161 | 251,109 | 93,642 | 79,204 |
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 9,141 | 66,859 | 54,923 | 7,487 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Minority Interest | ||||
Total Other Liabilities | ||||
Total Funded Status | ||||
Total Liabilities | 48,328 | 119,000 | 84,201 | 32,554 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
ESOP Debt Guarantee | ||||
Other Equity | ||||
Total Equity | 180,833 | 132,109 | 9,440 | 46,650 |
Total Liabilities & Shareholders' Equity | 229,161 | 251,109 | 93,642 | 79,204 |
Total Common Shares Outstanding |